慢性淋巴细胞白血病中免疫球蛋白重链增强子劫持的谱系
该研究对144例排除IGH::BCL2、IGH::CCND1、IGH::BCL3和IGH::MYC的IGH易位CLL样本进行综合分析,鉴定出25个IG易位伙伴,其中12个为既往未报道。研究揭示断裂点多由异常类别转换重组驱动,并发现NKX2.6和METRNL等新伙伴基因。
要点
- 在IGH易位CLL中鉴定出25个IG伙伴基因,12个为新发现。
- 78%的可评估病例断裂点由异常类别转换重组驱动。
- NKX2.6和METRNL为新的IGH易位伙伴基因。
核心结论
- 研究扩展了CLL中靶向IGH的致癌易位伙伴谱系,发现12个既往未报道的伙伴基因。
研究设计与样本
- 对144例排除IGH::BCL2、IGH::CCND1、IGH::BCL3和IGH::MYC的IGH易位CLL样本进行综合分析。
- 结合FISH、全基因组测序、靶向测序和RNA表达谱分析。
主要发现
- 142例中107例(75%)为未突变IGHV。
- 41例可评估病例中32例(78%)断裂点由异常类别转换重组驱动,IGHM和IGHG3各占9/41。
- 3例未突变IGHV病例因非法VDJ重组导致IGH位点与8p21.2的完整NKX2.6基因并置,伴NKX2.6转录显著异位上调(FDR < 0.001,logFC: 15)。
- METRNL位于17q25端粒,在4例中被鉴定为易位伙伴基因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Activation of oncogenes by hijacking immunoglobulin gene loci (IG) enhancers via chromosomal translocation is a common pathogenetic mechanism in B-cell malignancies, affecting 5-10% of chronic lymphocytic leukemia (CLL). The oncogenic partners in many of these cases remain unidentified. Therefore, we conducted a comprehensive analysis of 144 CLL samples with IGH-translocation excluding IGH::BCL2, IGH::CCND1, IGH::BCL3 and IGH::MYC. By combining fluorescence in situ hybridization (FISH) with whole-genome, targeted sequencing, and RNA expression profiling, we identified 25 IG-translocation partners; 12 were previously unreported. Of 142 cases, 107 (75%) displayed an unmutated IGHV. Genetic profiling showed a heterogenous distribution of chromosomal aberrations and recurrently mutated genes across the groups. Of 41 informative cases, 32 (78%) exhibited breakpoints driven by aberrant class-switch recombination (CSR), with prominent involvement of IGHM (9/41) and IGHG3 (9/41). Three cases with unmutated IGHV carried a juxtaposition of the IGH locus 5' to the intact NKX2.6 gene in chromosome 8p21.2 due to illegitimate VDJ recombination, associated with significant ectopic upregulation of NKX2.6 transcriptional expression (FDR < 0.001, logFC: 15). Similarly, METRNL, located at the telomere of chromosome 17q25, was identified as a translocation partner gene in four cases. Our findings expand the spectrum of the oncogenic translocation partners targeting IGH in CLL.
引用
- Drewes C, López C, Okeke N, et al. The spectrum of immunoglobulin heavy chain enhancer hijacking in chronic lymphocytic leukemia. Leukemia. 2026. PMID: 42026179. doi:10.1038/s41375-026-02902-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。